Better Access Australia and AusPIPS Inc have welcomed the expanded funded access via the National Immunisation Program to GSK's shingles vaccine, Shingrix, to include immunocompromised patients.
Groups welcome wider access to shingles vaccine for immunocompromised patients
September 6, 2024 Latest NewsBioPharmaNews of the DayLatest Video
New Stories
-
Australian company Kazia executes licensing agreement with QIMR Berghofer
September 16, 2024 - - Latest News -
A statement with intent that limits expectations and frames reform as a one-sided trade-off
September 16, 2024 - - Latest News -
The HTA Review report - 'Red Flag' number one of five
September 16, 2024 - - Latest News -
Pharmac announces plan to deploy more of its recent funding boost
September 16, 2024 - - Latest News -
In 236 pages, this one section captures the primary barrier to real reform
September 13, 2024 - - Latest News -
It is never too late for a considered response - caution
September 13, 2024 - - Latest News -
The 'Week in Review' Podcast - 13 September
September 12, 2024 - - Podcast